排序方式:
1.Management of Chinese patients on warfarin therapy in two models of anticoagulation service - a prospective randomized trial
Chan, FWH, Wong, RSM
More...
Chan, FWH, Wong, RSM, Lau, WH, Chan, TYK, Cheng, G, You, JHS
Less
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY[0306-5251],
Published 2006,
Volume 62,
Issue 5,
Pages 601-609
收錄情况:
WOS
SCOPUS
WOS核心合集引用: 46
2023影響因子:
3.1
发表年影響因子:
2.718
2.Is INR between 2.0 and 3.0 the optimal level for Chinese patients on warfarin therapy for moderate-intensity anticoagulation?
You, JHS, Chan, FWH,
More...
You, JHS, Chan, FWH, Wong, RSM, Cheng, G
Less
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY[0306-5251],
Published 2005,
Volume 59,
Issue 5,
Pages 582-587
收錄情况:
WOS
SCOPUS
WOS核心合集引用: 116
2023影響因子:
3.1
发表年影響因子:
2.777